SCHEMBL30262115

SCHEMBL30262115

CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(C)C)[C@@H](C)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C

nearest known ligand 0.63

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ CXCR4 P61073 11/20 0.63
▸ CALCA P06881 2/20 0.57
▸ NPY1R P25929 1/20 0.56
▸ NPY2R P49146 1/20 0.56
▸ NPY4R P50391 1/20 0.56
▸ NPY5R Q15761 1/20 0.56
▸ IL23R Q5VWK5 1/20 0.55
▸ KEAP1 Q14145 1/20 0.53
▸ PTH1R Q03431 1/20 0.53
▸ C5AR1 P21730 1/20 0.53
▸ KISS1R Q969F8 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30512621 0.90 CXCR4 (0.64) CXCR4CALCANPY1RNPY2RNPY4R
SCHEMBL30495697 0.88 NPY1R (0.68) CXCR4CALCANPY1RNPY2RNPY4R
SCHEMBL30495787 0.88 C5AR1 (0.66) CXCR4CALCANPY1RNPY2RNPY4R
SCHEMBL30658309 0.88 KEAP1 (0.68) CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL29444580 0.87 C5AR1 (0.62) CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL31182984 0.87 CXCR4 (0.69) CXCR4CALCA
SCHEMBL29416050 0.86 CXCR4 (0.66) CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL30646301 0.86 CXCR4 (0.66) CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL31182589 0.86 NPY1R (0.68) CXCR4CALCANPY1RNPY2RNPY4R
SCHEMBL29645132 0.86 CXCR4 (0.62) CXCR4NPY1RNPY2RNPY4RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230040544-A1 COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) SAREPTA THERAPEUTICS, INC. 2023-02-09 — — US disclosed
Send feedback